Corinne Faivre-Finn, MD PhD

CONTACT

Julie Stratford

CONTACT

Lead Sponsor

Sally Falk

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

•Patients to be treated with radical RT for prostate cancer
•Patients to be treated with VMAT
•ECOG performance status 0-2
•Patients must be able to receive and understand verbal and written information regarding the study and give written, informed consent
•A histological or cytological diagnosis of non-small cell lung cancer or small cell lung cancer
•Patients to be treated with radical RT or SBRT
•Patients to be treated with VMAT
•ECOG performance status 0-2
•Patients must be able to receive and understand verbal and written information regarding the study and give written, informed consent
•Female patients must meet one of the following criteria - postmenopausal for a minimum of one year, surgically sterile, not pregnant, confirmed by β-HCG blood test and willing to use adequate contraception during study participation, not breastfeeding

•Clinical judgement by the investigator that the patient should not participate in the study
•Patients in clinical trials of new investigational medicinal products or treatment regimens unless there is written, prior agreement that the patient can also consent to this study, and that clinical data can also be used for this study
•Prior radiotherapy or surgery in the pelvis that can make identification of normal anatomy difficult
•Clinical judgement by the investigator that the patient should not participate in the study
•Patients in clinical trials of new investigational medicinal products or treatment regimens unless there is written, prior agreement that the patient can also consent to this study, and that clinical data can also be used for this study
•Prior radiotherapy or surgery in the region of interest that can make identification of normal anatomy difficult